Literature DB >> 24078988

Aflatoxins as a cause of hepatocellular carcinoma.

Michael C Kew1.   

Abstract

Aflatoxins, metabolites of the fungi Aspergillus flavus and Aspergillus parasiticus, are frequent contaminants of a number of staple foods, particularly maize and ground nuts, in subsistence farming communities in tropical and sub-tropical climates in sub-Saharan Africa, Eastern Asia and parts of South America. Contamination of foods occurs during growth and as a result of storage in deficient or inappropriate facilities. These toxins pose serious public health hazards, including the causation of hepatocellular carcinoma by aflatoxin B1. Exposure begins in utero and is life-long. The innocuous parent molecule of the fungus is converted by members of the cytochrome p450 family into mutagenic and carcinogenic intermediates. Aflatoxin-B1 is converted into aflatoxin B1-8,9 exo-epoxide, which is in turn converted into 8,9-dihydroxy-8-(N7) guanyl-9-hydroxy aflatoxin B1 adduct. This adduct is metabolized into aflatoxin B1 formaminopyrimidine adduct. These adducts are mutagenic and carcinogenic. In addition, an arginine to serine mutation at codon 249 of the p53 tumor suppressor gene is produced, abrogating the function of the tumor suppressor gene, and contributing to hepatocarcinogenesis. Aflatoxin B1 acts synergistically with hepatitis B virus in causing hepatocellular carcinoma. A number of interactions between the two carcinogens may be responsible for this action, including integration of hepatitis B virus x gene and its consequences, as well as interference with nucleotide excision repair, activation of p21waf1/cip1, generation of DNA mutations, and altered methylation of genes. But much remains to be learnt about the precise pathogenetic mechanisms responsible for aflatoxin B1-induced hepatocellular carcinoma as well as the interaction between the toxin and hepatitis B virus in causing the tumor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078988

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  68 in total

1.  Reflections on nutritional cancer epidemiology.

Authors:  Paolo Boffetta
Journal:  Am J Clin Nutr       Date:  2015-12-16       Impact factor: 7.045

2.  The effects of season and gender on the serum aflatoxins and ochratoxin A levels of healthy adult subjects from the Central Anatolia Region, Turkey.

Authors:  Suna Sabuncuoglu; Pinar Erkekoglu; Sevtap Aydin; Gönül Şahin; Belma Kocer-Gumusel
Journal:  Eur J Nutr       Date:  2014-07-25       Impact factor: 5.614

Review 3.  Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.

Authors:  Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2019-03-07

Review 4.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

5.  Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.

Authors:  Saleh A Alqahtani; Faisal M Sanai; Ashwaq Alolayan; Faisal Abaalkhail; Hamad Alsuhaibani; Mazen Hassanain; Waleed Alhazzani; Abdullah Alsuhaibani; Abdullah Algarni; Alejandro Forner; Richard S Finn; Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2020-10       Impact factor: 2.485

Review 6.  Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

Authors:  Aastha Jindal; Anusha Thadi; Kunwar Shailubhai
Journal:  J Clin Exp Hepatol       Date:  2019-01-25

7.  Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.

Authors:  Patrick Kwok Shing Ng; Carol Po Ying Lau; Emily Kai Yee Lam; Sheila Sai Kam Li; Vivian Wai Yan Lui; Winnie Yeo; Yuen Keng Ng; Paul Bo San Lai; Stephen Kwok Wing Tsui
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

8.  Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.

Authors:  Anna Fishbein; Weicang Wang; Haixia Yang; Jun Yang; Victoria M Hallisey; Jianjun Deng; Sanne M L Verheul; Sung Hee Hwang; Allison Gartung; Yuxin Wang; Diane R Bielenberg; Sui Huang; Mark W Kieran; Bruce D Hammock; Dipak Panigrahy
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-14       Impact factor: 11.205

Review 9.  Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study.

Authors:  Bogdan I Fedeles; John M Essigmann
Journal:  DNA Repair (Amst)       Date:  2018-08-25

Review 10.  Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC).

Authors:  Indranil Banerjee; Paul B Fisher; Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2021-06-16       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.